Drug Policy Archives - Page 12 of 57

A glimpse into Colorado’s emerging legal pyschedelics scene

Commentary by Gregory Ferenstein

How the FDA can safely approve a promising but controversial mental health drug

Commentary by Gregory Ferenstein and Geoffrey Lawrence

A Schedule III designation is still overly restrictive for marijuana

Testimony by Geoffrey Lawrence and Jacob James Rich

States can legalize MDMA for pharmaceutical use even if the federal government does not

Commentary by Gregory Ferenstein

New Jersey Senate Bill 2283 would decriminalize psilocybin

Testimony by Leonard Gilroy, Geoffrey Lawrence and Gregory Ferenstein

Psychedelics Policy Newsletter: Massachusetts ballot initiative would foster access, state legislature momentum stalls, and more

Psychedelics Policy Newsletter by Gregory Ferenstein

State psychedelics legalization and policy roundup — May 2024

Commentary by Gregory Ferenstein

Alaska considers much needed reduction in marijuana taxes

Commentary by Madison Carlino

The prospects and perils of rescheduling cannabis

Commentary by Michelle Minton

More Drug Policy